Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 501 - 550 out of 1,379

Document Document Title
JP2007524627A
The present invention relates to the method and composite which increase intracellular telomerase activity. Such a composite contains medicines, such as a partial prescription thing and a nutrition prescription thing. This method and the...  
JP2007210888A
To provide a new method for producing a steroid compound. The present invention provides a method for producing 5β-3,7-dioxocholanic acid or its ester derivative by passing through the following four steps (I) to (IV) by using cholesta-...  
JPWO2005095436A1
3−O−β−D−グルコピラノシル−4−メ ルエルゴスト−7−エン−3−オール、又 同化合物を含むユリ科植物の抽出物又はそ 分画物であって、前記化合物を0.0...  
JP2007520455A
The present invention offers the エクジ steroid derivative which combined the fluorescence portion with the エクジ steroid portion by derivative-izing the hydroxyl machine on the alkyl side chain of a エクジ steroid portion. Thi...  
JP2007145782A
To obtain an extract having high blood sugar level depressing action from Momordica charantia of a natural plant, and to provide a blood sugar level depressant containing the same, and a food/pharmaceutical composition containing this ex...  
JP2007126466A
To provide an enzyme inhibition immunoassay for the measurement of an analyte in biological samples.This invention provides a method for the measurement of an analyte in biological samples whereby an uncompetitive inhibitor is coupled to...  
JP2002540119A5  
JP3902255B2
To provide the subject new compound having excellent antiinflammatory action and low systemic side actions and useful e.g. for an extremely strong local antiinflammatory agent by reacting deoxymethasone, etc., with an activated aromatic ...  
JPWO2007034851A
It is a 3* O*beta*D * glucopyranosyl *4* methyl ergost *7* エン *3* oar in order to prevent or improve the viscera adipose obesity which reduces the fat accumulated into the abdominal cavity and is considered to be the main causes of m...  
JP2007506681A
The present invention offers the method for dealing with a respiratory ailment. Offering the method for the disposal of asthma including prescribing for the patient the medicine tablet of a medical treatment effective amount which contai...  
JP2007505109A
New isolation, refining ウィタナミド, and ウィタノリド are indicated. Although especially the compound from the fruits of ウィタニアソムニフェラ is a desirable source of ウィタナミド and ウィタノリド, t...  
JP2007051148A
To provide a new steroid compound useful as an anti-estrogenic agent.The new steroid compound is a 17-desoxy-1,3,5(10)-estratriene, being such that a molecular moiety of the chemical formula is substituted at the C-11 or C-17 position on...  
JP3883563B2  
JP2006312649A
To provide a formulation for treatment of asthma free from CFC and a process for preparing the same, having desired solubility, stability, low toxicity, practical dosage, accurate particle size (in suspension) and/or avoiding defects man...  
JPWO2005007172A1
本発明は、抗腫瘍剤として有用なコレスタノ ール配糖体の効果を最大限に発揮し得る製剤 を提供するものである。 すなわち、本発明は、抗腫瘍活性を有し、糖 としてGlc...  
JP2006522808A
By medicating a 験-ed object with an effective quantity of a glycolipid therapeutically, the characteristic compound which can be used in order to guide the immune response to ボレリア ブルグドルフェリ (Borrelia burgdorferi)...  
JP2006521338A
The compound of formula (I) is offered. R among a formula, アルキルオキシ alkyl group; -- nitrile group; -- except C. The アルケニル aryl group; アルキル hetero aryl group; アルケニル hetero aryl group; =N*O* alkyl g...  
JP2004505990A5  
JP3814312B2
PURPOSE: To obtain the subject new derivative having anti-glucocorticoid activity and usable in treating or preventing glucocorticoid-dependent diseases such as diabetes, hypertension and arteriosclerosis. CONSTITUTION: This new 11,12-bi...  
JP2006176428A
To develop drug(s) in view of the fact that neurodegenerative diseases including Alzheimer's disease, senile dementia, cerebrovascular dementia and Parkinson's disease means symptoms presenting disorders in memory and/or cognizance by ne...  
JP3793602B2
To obtain a new steroid glycoside which is obtained by extraction of a plant in liliaceae plant and is a specific steroid glycoside, shows high anticancer action and high immunosuppression with high safety and is useful as an active ingr...  
JP2006151994A
To provide a simple method for converting a pregnane-3,20-dione compound into a 3α-hydroxy-3β-substituted-pregnane.An unprotected dione is chemoselectively and stereoselelctively converted into a 3(R)-pregnane-3-spiro-2'-oxiran-20-one ...  
JP3779744B2
PURPOSE: To obtain a new monosaccharide derivative comprising a monosaccharide derivative having a sterol residue and a polyoxyethylene chain, and capable of prolonging a residence time of medicine in blood when being blended with the me...  
JP3780007B2
PURPOSE: To obtain a corticosteroid 17-alkyl carbonate 21-[0]-carboxylic acid carbonic ester which has a very strong local and topical anti-inflammatory action and is effctive in treating inflammatory dermatosis by reacting a specific al...  
JP2006515303A
The present invention relates to the hyaluronan formation catalyst containing the ジンセノ side compound K. The effect of all 20* O*beta*D * guru コピラノシル *20 (S) * pro トパナキサジ (compound K) that the present inven...  
JP3778372B2
PURPOSE: To obtain a new compound useful as a therapeutic agent for geriatric dementia, etc., including Alzheimer's disease, due to its activity of activating ChAT in cholinergic neurocytes. CONSTITUTION: A compound of formula I [R1 is a...  
JP2006508962A5  
JP2006508963A
withanolide which checks cyclooxygenase *2 enzyme is described. The compound of Withania somnifera origin may be a desirable source of supply of withanolide, and, on the other hand, they may especially be of the source-of-supply origin o...  
JP2006508962A
The present invention here about the production method of a new 7* カルボキシ substitution steroid compound with which it is expressed by the formula I R, They are H or COR. ; R is C*C アルキル or C*C アルコキシ. ; Z, It is...  
JP3746174B2  
JP2006502172A
A crystalline lattice is a crystalline chemistry complex with stable existence of a guest molecule containing the compound denoted by formula (I), The crystalline chemistry complex characterized by consisting of the space group P222 whic...  
JP2005538070A
The present invention is related to the new compound of (a) type (I). M is the character accumulated into an inflammatory cell a macrocode subunit (macrolide portion) originating in the macrolide which it has among a formula, and V, It i...  
JP2005537278A
A crystalline lattice is a crystalline chemistry complex with stable existence of a guest molecule containing the compound denoted by formula (I), The crystalline chemistry complex characterized by consisting of the space group P222 whic...  
JP2005535611A
[Subject] Those use in the medical treatment or prevention of new Andros Than, the Andros Teng derivative and various illnesses, a disease, and an obstacle accompanied by ascorbic acid. [Solution means] The present invention contains the...  
JP3717511B2  
JPWO2004007370A1
本発明によれば、無機鉱物のカチオンの全て または一部がH+に置換され、テクトケイ酸 塩骨格を有するゼオライトを含む、プロトン 交換型ゼオライト類似体を生成するため...  
JP3710470B2  
JPWO2005095436A
It is an extract of the department plant of Yuri containing a 3* O*beta*D * glucopyranosyl *4* methyl ergost *7* エン *3* oar or the compound, or its fraction, and let the constituent as for which more than 0.001 mass % contains the ab...  
JP2005528353A
[Subject] The method of treating the diabetes in an animal, especially humans is offered. The [solution means] following compound; formula (I, II, III) : (R among a formula a phytosterol or a フィトスタノール portion) [express an...  
JP2005527496A
According to one mode of the present invention, the medicine tablet for inhalation medication which has a remedially useful effect in the medical treatment of the inflammation obstacle of a breathing tube over the period of 24 hours or m...  
JP2005527497A
In the crystalline complex in which a crystalline lattice contains the compound of formula (I) with stable existence of a guest molecule, The crystalline complex in which the above-mentioned crystalline complex is characterized by being ...  
JP2005523267A
By the present invention, the inside of the glucocorticoid [化 1] [type of formula (I) as (a) medicine, R shows the heterocyclic aromatic ring of 5 members containing 1*3 hetero atoms chosen from ethyl or O, N, and S, and may be replace...  
JP2005522442A
According to one mode of the present invention, the compound of formula (I) which is a form of a noncrystalline solid substantially is offered.  
JP2005521673A
The medicine tablet containing the water suspension thing of the particle-like compound of formula (I) or its solvation thing is offered. [化 1]  
JP2005519925A
(i) the compound of formula (I) as a medicine or its solvation thing, and (ii) -- the aerosol drug for medicines characterized by the compound or its solvation thing of formula (I) dissolving completely into a tablet is offered including...  
JP2005179370A
To provide a method and to obtain a composition for causing the interaction with a GABAA (γ-aminobutyric acid A) receptor complex to induce sleep in Homo sapiens.In the sleep induction method, a 3α-hydroxy-5-reduced steroid derivative ...  
JP2005513024A
The present invention relates to the medical treatment method of the patient of the major depression sexual disorder by medicating a patient with an effective amount of glucocorticoid receptor antagonists, and the method for setting up t...  
JP2005509642A
A new anti-inflammatory Andros Than derivative. The compound of formula (I) : Inside of a [化 1] [type: R shows O, S, or NH. ; R shows -C (=O) -アリール or C (=O) -ヘテロア reel, and; R Hydrogen, Methyl (any of alpha or beta con...  
JP2005500290A
Among a formula (I) [type, R expresses C アルキル or C halo アルキル, and; R, . You may be replaced by one or more methyl groups, ethyl groups, or halogen groups depending on the case. Express the non-aromatic series ring of the ...  
JPWO2003022866A1
下記一般式(1)で示されるコレステロール 誘導体は、β2−グリコプロテインに特異的 結合するため、この誘導体を利用すること よりβ2−グリコプロテイン等を極め...  

Matches 501 - 550 out of 1,379